Overview

Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This is an investigator-sponsored trial (IST), an open-label pilot study, assessing the safety and biologic activity of bromfenac in subjects with diffuse DME refractory to laser.

Phase:

Phase 1

Details

Lead Sponsor:

Ophthalmic Consultants of Boston

Collaborator:

Bausch & Lomb Incorporated

Treatments:

Bromfenac
Ophthalmic Solutions
Pharmaceutical Solutions